BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rinaldi L, Nascimbeni F, Giordano M, Masetti C, Guerrera B, Amelia A, Fascione MC, Ballestri S, Romagnoli D, Zampino R, Nevola R, Baldelli E, Iuliano N, Rosato V, Lonardo A, Adinolfi LE. Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. World J Gastroenterol 2017; 23(8): 1458-1468 [PMID: 28293093 DOI: 10.3748/wjg.v23.i8.1458]
URL: https://www.wjgnet.com/1948-5182/full/v23/i8/1458.htm
Number Citing Articles
1
Francesco Angelico, Stefano Ginanni Corradini, Daniele Pastori, Silvia Fargion, Anna Ludovica Fracanzani, Mario Angelico, Luigi Bolondi, Giulia Tozzi, Pietro Luigi Pujatti, Giancarlo Labbadia, Gino Roberto Corazza, Maurizio Averna, Francesco Perticone, Giuseppe Croce, Marcello Persico, Tommaso Bucci, Francesco Baratta, Licia Polimeni, Maria Del Ben, Francesco Violi, Francesco Violi, Francesco Angelico, Daniele Pastori, Francesco Baratta, Maria Del Ben, Licia Polimeni, Giancarlo Labbadia, Stefania Basili, Valeria Raparelli, Laura Napoleone, Stefano Ginanni Corradini, Flaminia Ferri, Pellone Monica, Monica Mischitelli, Parlati Lucia, Giulia Tozzi, Jessica D'Amico, Marina Colzi, Paola Andreozzi, Francesco Perticone, Benedetto Caroleo, Gino Roberto Corazza, Masotti Michela, Bergamaschi Gaetano, David Sacerdoti, Silvia Brocco, Mario Angelico, Francesco Santopaolo, Simona Francioso, Pietro Luigi Pujatti, Alessandra Faedo, Angelo Andriulli, Antonio M. Ippolito, Luigi Bolondi, Francesco Tovoli, Silvia Fargion, Anna Ludovica Fracanzani, Giovanni Davì, Dario Di Michele, Giuseppe Croce, Maurizio Averna, Antonina Giammanco, Marcello Persico, Tommaso Bucci, Luigi Iuliano, Marco Ciacciarelli. Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort studyAtherosclerosis 2017; 262: 179 doi: 10.1016/j.atherosclerosis.2017.03.038
2
Amedeo Lonardo, Stefano Ballestri. Perspectives of nonalcoholic fatty liver disease research: a personal point of viewExploration of Medicine 2020; 1(3): 85 doi: 10.37349/emed.2020.00007
3
Fabio Nascimbeni, Stefano Ballestri, Mariana Verdelho Machado, Alessandro Mantovani, Helena Cortez-Pinto, Giovanni Targher, Amedeo Lonardo. Clinical relevance of liver histopathology and different histological classifications of NASH in adultsExpert Review of Gastroenterology & Hepatology 2018; 12(4): 351 doi: 10.1080/17474124.2018.1415756
4
Pratima Dibba, Rosann Cholankeril, Andrew Li, Meera Patel, Mariam Fayek, Christy Dibble, Nnenna Okpara, Autumn Hines, Aijaz Ahmed. Hepatitis C in PregnancyDiseases 2018; 6(2): 31 doi: 10.3390/diseases6020031
5
K. Rosenqvist, R. Sheikhi, R. Nyman, F. Rorsman, P. Sangfelt, C. Ebeling Barbier. Transjugular intrahepatic portosystemic shunt treatment of variceal bleeding in an unselected patient populationScandinavian Journal of Gastroenterology 2018; 53(1): 70 doi: 10.1080/00365521.2017.1386795
6
Amedeo Lonardo, Fabio Nascimbeni, Mauro Maurantonio, Alessandra Marrazzo, Luca Rinaldi, Luigi Elio Adinolfi. Nonalcoholic fatty liver disease: Evolving paradigmsWorld Journal of Gastroenterology 2017; 23(36): 6571-6592 doi: 10.3748/wjg.v23.i36.6571
7
Mohammad Reza Ghadir, Seyed Saeed Sarkeshikian, Ahmad Hormati, Faezeh Alemi, Pezhman Alavinejad, Maryam Jameshorani, Mansoureh Molaei, Mahdi Jahangiry. Efficacy of Atorvastatin Plus Aspirin in Comparison with Atorvastatin Alone on Liver Function and Degree of Fibrosis in Patients with Cryptogenic Cirrhosis: A Randomized Double-Blind Clinical TrialHepatitis Monthly 2019; 19(11) doi: 10.5812/hepatmon.92342
8
Bei Li, Chuan Zhang, Yu-Tao Zhan. Nonalcoholic Fatty Liver Disease Cirrhosis: A Review of Its Epidemiology, Risk Factors, Clinical Presentation, Diagnosis, Management, and PrognosisCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/2784537
9
Yuping Ding, Quanjun Deng, Mei Yang, Haiyan Niu, Zuoyu Wang, Shihai Xia. Clinical Classification of Obesity and Implications for Metabolic Dysfunction-Associated Fatty Liver Disease and TreatmentDiabetes, Metabolic Syndrome and Obesity 2023; : 3303 doi: 10.2147/DMSO.S431251
10
Luca Rinaldi, Pia Clara Pafundi, Raffaele Galiero, Alfredo Caturano, Maria Vittoria Morone, Chiara Silvestri, Mauro Giordano, Teresa Salvatore, Ferdinando Carlo Sasso. Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative ReviewAntioxidants 2021; 10(2): 270 doi: 10.3390/antiox10020270
11
Erica Vetrano, Luca Rinaldi, Andrea Mormone, Chiara Giorgione, Raffaele Galiero, Alfredo Caturano, Riccardo Nevola, Raffaele Marfella, Ferdinando Carlo Sasso. Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic StrategiesBiomedicines 2023; 11(2): 468 doi: 10.3390/biomedicines11020468
12
Masanori Fukushima, Hisamitsu Miyaaki, Ryu Sasaki, Masafumi Haraguchi, Satoshi Miuma, Takanobu Hara, Akihiko Soyama, Masaaki Hidaka, Susumu Eguchi, Kazuhiko Nakao. Most Cases of Cryptogenic Cirrhosis May Be Nonobese Nonalcoholic Steatohepatitis - Risk Factors of Liver Steatosis After Liver Transplantation for Cryptogenic Cirrhosis: A Retrospective StudyInternal Medicine 2023; 62(10): 1415 doi: 10.2169/internalmedicine.0514-22
13
Hiroji Shinkawa, Shogo Tanaka, Shigekazu Takemura, Tokuji Ito, Takanori Aota, Toru Miyazaki, Shoji Kubo. Outcomes of Non-B Non-C Hepatocellular Carcinoma with Reference to Patients with Interferon-Induced Hepatitis C Virus EradicationJournal of Gastrointestinal Surgery 2020; 24(8): 1809 doi: 10.1007/s11605-019-04339-1
14
Dzeina Mezale, Ilze Strumfa, Andrejs Vanags, Matiss Mezals, Ilze Fridrihsone, Boriss Strumfs, Dainis Balodis. Liver Cirrhosis - Update and Current Challenges2017;  doi: 10.5772/intechopen.68771
15
Anna Kleczka, Bogdan Mazur, Krzysztof Tomaszek, Andrzej Gabriel, Radosław Dzik, Agata Kabała-Dzik. Association of NK Cells with the Severity of Fibrosis in Patients with Chronic Hepatitis CDiagnostics 2023; 13(13): 2187 doi: 10.3390/diagnostics13132187
16
Luca Rinaldi, Erica Vetrano, Barbara Rinaldi, Raffaele Galiero, Alfredo Caturano, Teresa Salvatore, Ferdinando Carlo Sasso. HCC and Molecular Targeting Therapies: Back to the FutureBiomedicines 2021; 9(10): 1345 doi: 10.3390/biomedicines9101345
17
Yen-Po Lin, Pei-Ming Wang, Ching-Hui Chuang, Chee-Chen Yong, Yueh-Wei Liu, Pao-Yuan Huang, Chih-Chien Yao, Ming-Chao Tsai. Metabolic Risks Are Increasing in Non-B Non-C Early-Stage Hepatocellular Carcinoma: A 10-Year Follow-Up StudyFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.816472
18
Patricia C. Valery, Steven McPhail, Katherine A. Stuart, Gunter Hartel, Paul J. Clark, James O'Beirne, Richard Skoien, Tony Rahman, Chris Moser, Elizabeth E. Powell. Changing prevalence of aetiological factors and comorbidities among Australians hospitalised for cirrhosisInternal Medicine Journal 2021; 51(5): 691 doi: 10.1111/imj.14809
19
Young Joo Yang, Chang Seok Bang, Suk Pyo Shin, Gwang Ho Baik, Giovanni Targher. Clinical impact of non-alcoholic fatty liver disease on the occurrence of colorectal neoplasm: Propensity score matching analysisPLOS ONE 2017; 12(8): e0182014 doi: 10.1371/journal.pone.0182014
20
Phunchai Charatcharoenwitthaya, Ngamphol Soonthornworasiri, Khemajira Karaketklang, Kittiyod Poovorawan, Wirichada Pan-ngum, Watcharasak Chotiyaputta, Tawesak Tanwandee, Kamthorn Phaosawasdi. Factors affecting mortality and resource use for hospitalized patients with cirrhosisMedicine 2017; 96(32): e7782 doi: 10.1097/MD.0000000000007782
21
Jui-Kun Chiang, Lin Chih-Wen, Yee-Hsin Kao. Effect of ultrasonography surveillance in patients with liver cancer: a population-based longitudinal studyBMJ Open 2017; 7(6): e015936 doi: 10.1136/bmjopen-2017-015936
22
Mohamed Mourad, Fanny Lebossé, Philippe Merle, Massimo Levrero, Teresa Antonini, Mickaël Lesurtel, Christian Ducerf, Fabien Zoulim, Jean‐Yves Mabrut, Kayvan Mohkam. External validation of the French alpha‐fetoprotein model for hepatocellular carcinoma liver transplantation in a recent unicentric cohort – a retrospective studyTransplant International 2021; 34(3): 535 doi: 10.1111/tri.13819
23
Shi-Ye Yang, Mao-Lin Yan, Jin-Kai Feng, Yun-Fei Duan, Jia-Zhou Ye, Zong-Han Liu, Lei Guo, Jie Xue, Jie Shi, Wan Yee Lau, Shu-Qun Cheng, Wei-Xing Guo. Impact of type 2 diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after laparoscopic liver resection: A multicenter retrospective studyFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.979434
24
Amedeo Lonardo, Alessandro Mantovani, Simonetta Lugari, Giovanni Targher. Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesityAnnals of Hepatology 2020; 19(4): 359 doi: 10.1016/j.aohep.2020.03.001
25
Riccardo Nevola, Domenico Beccia, Valerio Rosato, Rachele Ruocco, Davide Mastrocinque, Angela Villani, Pasquale Perillo, Simona Imbriani, Augusto Delle Femine, Livio Criscuolo, Maria Alfano, Marco La Montagna, Antonio Russo, Raffaele Marfella, Domenico Cozzolino, Ferdinando Carlo Sasso, Luca Rinaldi, Aldo Marrone, Luigi Elio Adinolfi, Ernesto Claar. HBV Infection and Host Interactions: The Role in Viral Persistence and OncogenesisInternational Journal of Molecular Sciences 2023; 24(8): 7651 doi: 10.3390/ijms24087651
26
Melanie Zheng, Garrett Allington, Sílvia Vilarinho. Genomic medicine for liver diseaseHepatology 2022; 76(3): 860 doi: 10.1002/hep.32364
27
Hitoshi Yoshiji, Tadashi Namisaki, Kosuke Kaji, Sven Francque. Portal Hypertension VII2022; : 221 doi: 10.1007/978-3-031-08552-9_19
28
Amedeo Lonardo, Giovanni Targher. NAFLD: Is There Anything New under the Sun?International Journal of Molecular Sciences 2017; 18(9): 1955 doi: 10.3390/ijms18091955
29
Wen Deng, Zimin Meng, Aitao Sun, Zhihong Yang. Pioglitazone suppresses inflammation and fibrosis in nonalcoholic fatty liver disease by down-regulating PDGF and TIMP-2: Evidence from in vitro studyCancer Biomarkers 2017; 20(4): 411 doi: 10.3233/CBM-170157
30
Ferdinando Carlo Sasso, Pia Clara Pafundi, Alfredo Caturano, Raffaele Galiero, Erica Vetrano, Riccardo Nevola, Salvatore Petta, Anna Ludovica Fracanzani, Carmine Coppola, Vito Di Marco, Antonio Solano, Rosa Lombardi, Mauro Giordano, Antonio Craxi, Alessandro Perrella, Celestino Sardu, Raffaele Marfella, Teresa Salvatore, Luigi Elio Adinolfi, Luca Rinaldi. Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetesNutrition, Metabolism and Cardiovascular Diseases 2021; 31(8): 2345 doi: 10.1016/j.numecd.2021.04.016
31
Chandrashekaraiah Bharath Kumar, Ashish Goel, Rajeeb Jaleel, Deepu David, Uday Zachariah, Jeyamani Ramachandran, Chundamannil E. Eapen. Prevalence of Risk Factors for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Patients With Cryptogenic CirrhosisJournal of Clinical and Experimental Hepatology 2022; 12(2): 492 doi: 10.1016/j.jceh.2021.05.008
32
Valerio Rosato, Antonio Ascione, Riccardo Nevola, Anna Ludovica Fracanzani, Guido Piai, Vincenzo Messina, Ernesto Claar, Carmine Coppola, Luca Fontanella, Rosa Lombardi, Laura Staiano, Giovanna Valente, Maria Chiara Fascione, Chiara Giorgione, Annalisa Mazzocca, Raffaele Galiero, Pasquale Perillo, Aldo Marrone, Ferdinando Carlo Sasso, Luigi Elio Adinolfi, Luca Rinaldi. Factors affecting long‐term changes of liver stiffness in direct‐acting anti‐hepatitis C virus therapy: A multicentre prospective studyJournal of Viral Hepatitis 2022; 29(1): 26 doi: 10.1111/jvh.13617
33
Aaron Hakim, Xuchen Zhang, Angela DeLisle, Elif A. Oral, Daniel Dykas, Kaela Drzewiecki, David N. Assis, Marina Silveira, Jennifer Batisti, Dhanpat Jain, Allen Bale, Pramod K. Mistry, Silvia Vilarinho. Clinical utility of genomic analysis in adults with idiopathic liver diseaseJournal of Hepatology 2019; 70(6): 1214 doi: 10.1016/j.jhep.2019.01.036
34
Melanie Zheng, Aaron Hakim, Chigoziri Konkwo, Aimee M. Deaton, Lucas D. Ward, Marina G. Silveira, David N. Assis, AnnMarie Liapakis, Ariel Jaffe, Z. Gordon Jiang, Michael P. Curry, Michelle Lai, Michael H. Cho, Daniel Dykas, Allen Bale, Pramod K. Mistry, Silvia Vilarinho. Advancing diagnosis and management of liver disease in adults through exome sequencingeBioMedicine 2023; 95: 104747 doi: 10.1016/j.ebiom.2023.104747